Larson Financial Group’s Galectin Therapeutics GALT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,300	Closed	-$1.68K	–	3099
2024 Q4	$1.68K	Hold	1,300	–	–	﹤0.01%	1912
2024 Q3	$3.58K	Buy	+1,300	New	+$3.58K	﹤0.01%	1724